Medicine-InternationalBDGlobal Specialty Medicines

Medical Insights

Education, updates and industry insights from our healthcare team.

Targeted Therapy for Lung Cancer: EGFR, ALK and What They Mean
OncologyLung Cancer

Targeted Therapy for Lung Cancer: EGFR, ALK and What They Mean

Biomarker testing decides which lung cancer treatment works. A plain-language guide to EGFR, ALK, ROS1 and the targeted therapies matched to each.

2026-08-049 min read
Breast Cancer Treatment: How Subtype Decides Everything
OncologyBreast Cancer

Breast Cancer Treatment: How Subtype Decides Everything

Hormone receptor and HER2 status determine breast cancer treatment. A clear guide to endocrine therapy, CDK4/6 inhibitors, HER2 drugs and triple-negative options.

2026-07-308 min read
Hepatitis C Is Curable: What Direct-Acting Antivirals Changed
Infectious DiseaseHepatitis C

Hepatitis C Is Curable: What Direct-Acting Antivirals Changed

Modern hepatitis C treatment cures over 95% of patients in 8 to 12 weeks with oral tablets. Here is how direct-acting antivirals work and what treatment involves.

2026-07-227 min read
Biosimilars vs Generics: What Is Actually Different
EducationBiosimilars

Biosimilars vs Generics: What Is Actually Different

A generic is chemically identical; a biosimilar is highly similar but not identical. Here is why that distinction exists and what it means for patients.

2026-07-156 min read
How to Check a Medicine Is Genuine Before You Take It
SafetyEducation

How to Check a Medicine Is Genuine Before You Take It

Substandard and falsified medicines are a real risk when buying internationally. Practical checks on packaging, supplier and documentation that anyone can do.

2026-07-087 min read
Importing Prescription Medicine: The Paperwork You Need
LogisticsAccess

Importing Prescription Medicine: The Paperwork You Need

Personal importation of prescription medicine is legal in many countries within limits. What documentation is normally required and what commonly goes wrong.

2026-07-017 min read
Chronic Myeloid Leukaemia: How TKIs Turned It Manageable
HaematologyLeukaemia

Chronic Myeloid Leukaemia: How TKIs Turned It Manageable

CML went from fatal to a condition most patients live with normally. A guide to BCR-ABL, tyrosine kinase inhibitors, monitoring and treatment-free remission.

2026-06-248 min read
Rheumatoid Arthritis: Understanding DMARDs and Biologics
RheumatologyAutoimmune

Rheumatoid Arthritis: Understanding DMARDs and Biologics

Rheumatoid arthritis treatment follows a defined escalation from methotrexate to biologics and JAK inhibitors. What each class does and how treatment progresses.

2026-06-178 min read
Understanding GLP-1 Therapies: What Patients Should Know
DiabetesWeight Management

Understanding GLP-1 Therapies: What Patients Should Know

GLP-1 receptor agonists changed diabetes and weight management. How they work, what results to expect, side effects, and the questions worth asking first.

2026-06-108 min read
How Immunotherapy Is Changing Cancer Care
OncologyImmunotherapy

How Immunotherapy Is Changing Cancer Care

Checkpoint inhibitors let the immune system see cancer again. How PD-1, PD-L1 and CTLA-4 drugs work, who they help, and what side effects to watch for.

2026-05-208 min read
Cold Chain: Storing and Shipping Temperature-Sensitive Medicines
LogisticsSafety

Cold Chain: Storing and Shipping Temperature-Sensitive Medicines

Biologics lose potency if the cold chain breaks, and it does not always show. How temperature-controlled shipping works and what to check on arrival.

2026-04-287 min read
Why Specialty Medicine Access Varies So Much Between Countries
AccessGlobal Health

Why Specialty Medicine Access Varies So Much Between Countries

The same medicine can be routine in one country and unavailable in another. What drives the gap — registration, pricing, procurement — and what patients can do.

2026-04-147 min read